Insider selling
Traded Nov 11 · filed 3 days laterNot reported under a pre-arranged trading plan
A Puma Biotechnology director sold $121K of Puma Biotechnology shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Sep 30, 2026 · Filed Nov 16, 2026
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider selling
Traded Nov 11 · filed 3 days laterNot reported under a pre-arranged trading plan
A Puma Biotechnology director sold $121K of Puma Biotechnology shares. The filing does not indicate a pre-arranged trading plan.
Miller Michael Patrick (Director) plans to sell ~$121K of Puma Biotechnology
Planned, from payFund moves
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.